EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

1′- and 4′-Cyano Modified Adenosine Analogs Against Prototypic Flavivirus RNA-Dependent RNA Polymerases

Simon M Walker iD, Calvin J Gordon iD, Egor P Tchesnokov iD, Long Sun iD, Jing Zou, Xuping Xie iD, Nicholas C Riola iD, Vincent Cutillas, Venice Du Pont, Xiaofeng Zhao, Ting Wang, Jared Pitts iD und 5 weitere

Viruses · 2026

DOI: 10.3390/v18020257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Simon M Walker und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2E1, Canada. Hauptthemen laut MEDLINE: RNA-Dependent RNA Polymerase, Antiviral Agents, Flavivirus, Adenosine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Alberta Ministry of Technology and Innovation, Gilead Sciences, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flaviviruses are arthropod-borne RNA viruses associated with significant human diseases globally. There are no effective direct-acting antivirals approved to treat these viral infections. Given its critical role in viral replication, the RNA-dependent RNA polymerase (RdRp) is a logical target for antiviral drug development. Remdesivir (formerly GS-5734), a 1′-cyano modified C-adenosine monophosphate prodrug, was the first US Food and Drug Administration (FDA) approved antiviral for coronavirus disease 2019 (COVID-19) and was also shown to inhibit flavivirus replication. GS-7682, a 4′-cyano modified C-adenosine prodrug, exhibits a broad-spectrum antiviral activity. Here, we determined the anti-flavivirus potency of both remdesivir and GS-7682 and characterized their active triphosphate forms, GS-443902 and GS-646939, respectively, against a panel of purified flavivirus RdRps. These include dengue, Japanese encephalitis, West Nile, yellow fever, and Zika. Enzyme kinetics demonstrate efficient RNA incorporation of GS-443902 and GS-646939. GS-646939 acts as an immediate chain terminator. Conversely, GS-443902 acts through a template-dependent inhibition mechanism by impeding the incorporation of the complementary UTP. Both mechanisms correlate with anti-flavivirus activity, although remdesivir is generally superior. The data demonstrate that immediate chain termination is not necessarily a preferred mechanism of action of nucleotide analogs. Template-dependent inhibition should also be considered, especially for viruses lacking intrinsic proofreading activities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Dependent RNA PolymeraseAntiviral AgentsFlavivirusAdenosineAdenosine MonophosphateAlanineVirus ReplicationHumansWest Nile virusDengue VirusRNA ReplicationZika VirusYellow fever virusAnimals

Stichwörter der Autor:innen

GS-443902GS-646939RNA-dependent RNA polymeraseRdRpbroad-spectrum antiviralflavivirusesnucleotide analogremdesivir

Substanzen

RNA-Dependent RNA PolymeraseAntiviral AgentsAdenosineAdenosine MonophosphateremdesivirAlanine

Autor:innen und Institutionen

  • Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2E1, Canada.
  • Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Gilead Sciences, Inc., Foster City, CA 94404, USA.

ORCID-Profile: Simon M Walker, Calvin J Gordon, Egor P Tchesnokov, Long Sun, Xuping Xie, Nicholas C Riola, Jared Pitts, Dustin S Siegel, John P Bilello

Förderung

  • NIAID NIH HHS
  • Alberta Ministry of Technology and Innovation
  • Gilead Sciences, Inc.
  • National Institute of Allergy and Infectious Diseases of the National Institutes of Health

Zitieren

APA

Walker, S. M., Gordon, C. J., Tchesnokov, E. P., Sun, L., Zou, J., Xie, X., Riola, N. C., Cutillas, V., Du Pont, V., Zhao, X., Wang, T., Pitts, J., Siegel, D. S., Perry, J. K., Feng, J. Y., Bilello, J. P., & Götte, M. (2026). 1′- and 4′-Cyano Modified Adenosine Analogs Against Prototypic Flavivirus RNA-Dependent RNA Polymerases. Viruses. https://doi.org/10.3390/v18020257

Vancouver

Walker SM, Gordon CJ, Tchesnokov EP, Sun L, Zou J, Xie X, et al. 1′- and 4′-Cyano Modified Adenosine Analogs Against Prototypic Flavivirus RNA-Dependent RNA Polymerases. Viruses. 2026. doi:10.3390/v18020257

BibTeX
@article{Walker2026,
  author = {Walker, Simon M and Gordon, Calvin J and Tchesnokov, Egor P and Sun, Long and Zou, Jing and Xie, Xuping and Riola, Nicholas C and Cutillas, Vincent and Du Pont, Venice and Zhao, Xiaofeng and Wang, Ting and Pitts, Jared and Siegel, Dustin S and Perry, Jason K and Feng, Joy Y and Bilello, John P and Götte, Matthias},
  title = {1′- and 4′-Cyano Modified Adenosine Analogs Against Prototypic Flavivirus RNA-Dependent RNA Polymerases},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18020257}
}
Kostenlos starten →